Vigil Neuroscience (VIGL)
(Delayed Data from NSDQ)
$4.40 USD
+0.21 (5.01%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $4.26 -0.14 (-3.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
Vigil Neuroscience, Inc. [VIGL]
Reports for Purchase
Showing records 41 - 46 ( 46 total )
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Target Engagement - Check; Pathway Engagement - Check; On To Phase 2 For VGL101
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways From Vigil?s Interim Top Line Phase 1 HV Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
The Beginning of an Era of Anti-Amyloids and Combination Therapies in Alzheimer''s Disease
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at Outperform; Making Neurodegenerative Conditions Tremble
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Mobilizing the Vigilantes of the Brain to Tackle Neurodegeneration; Buy and PT $24
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A